Aehr Test Systems Stock 12‑Month Price Target Cut to $127, Implies 95% Upside

Aehr Test Systems' average stock price target was reduced from $127.83 to $127 by 5 analysts, with a range of $110 to $140. This implies a 95% upside from the Nov. 3 closing price. The consensus rating remains 'Buy' among 6 analysts.

Original reporting
Published Nov 4, 2026, 7:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 7:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aehr Test Systems Stock 12‑Month Price Target Cut to $127, Implies 95% Upside — source image
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

Analyst target revisions can influence short‑term price movement, especially for low‑float stocks.

02

Market read

A modest analyst downgrade with a still‑high upside estimate; limited trading relevance.

03

What to watch

Potential upcoming product launches or contract wins not mentioned could offset the modest downgrade.

Relevance 5/10Novelty 5/10Timing: today

Background

The article summarizes recent analyst consensus price target adjustments for Aehr Test Systems.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

Analysts lowered the average price target for Aehr Test Systems to $127 from $127.83, indicating a modest downgrade.

Expected impact

modest upward pressure as investors weigh the still‑high upside potential

Evidence & confidence

Target cut is minor and reflects a small adjustment rather than a material change in fundamentals.

Market effects

Minor impact on semiconductor test equipment sector; no broad sector shift.

Limited to U.S. small‑cap investors tracking AEHR.

Low; the news is company‑specific with no global macro implications.

Counterpoint

Some traders may view the target cut as a signal to short, betting the upside is overstated.

Key entities

  • Aehr Test Systems

    U.S. listed provider of test equipment for semiconductor manufacturers.

Related articles

$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.

$AEHRHighAI 9/10

AEHR Stock Surges After Massive AI-Driven Earnings Beat

Aehr Test Systems (AEHR) stock rose 26.6% after reporting Q1 FY27 revenue of $33M, up 300% year-over-year and 75% quarter-over-quarter. Adjusted EPS was $0.28, beating estimates. The company raised FY27 revenue guidance to $150M, citing strong demand for AI and power semiconductor testing.

$AEHRHighAI 9/10

Aehr Stock Jumps 16% After Bookings Hit $46.7 Million

Aehr Test Systems (AEHR) shares rose 16.38% premarket after its Q1 revenue tripled to $33.0M, beating estimates. The company raised its full-year outlook to $150M, citing strong bookings and backlog growth. CEO Gayn Erickson highlighted a major AI customer opportunity. According to GuruFocus, there are 6 warning signs with AEHR.

$AEHRHighAI 8/10

Why is Aehr Test Systems stock surging today?

Aehr Test Systems (AEHR) stock surged 18.8% in pre-market trading after reporting record Q1 2027 revenue of $33.0M, up 200% YoY, and raising full-year revenue outlook to $150M. Non-GAAP net income was $9.4M, or $0.28 per share, exceeding analyst estimates. The company cited strong demand for AI semiconductor test solutions and a book-to-bill ratio of 1.4.

$AEHRMed

Aehr stock jumps on beat and raise amid AI demand

Aehr Test Systems (AEHR) shares rose 15% after reporting Q1 revenue of $33M, up 200% YoY, and raising its FY2027 outlook to $150M. The company cited strong demand for its semiconductor testing systems used in AI chips. CEO Gayn Erickson noted a conservative approach to the revised target. Bookings were $46.7M with a book-to-bill ratio of 1.4.